Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;121(8):992-1007.
doi: 10.1055/a-1535-8807. Epub 2021 Jul 20.

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

Grigoris T Gerotziafas  1   2 Mariella Catalano  3 Yiannis Theodorou  4 Patrick Van Dreden  1 Vincent Marechal  1 Alex C Spyropoulos  5   6 Charles Carter  7 Nusrat Jabeen  8 Job Harenberg  9   10 Ismail Elalamy  1   2   6 Anna Falanga  11   12 Jawed Fareed  13   14 Petros Agathaggelou  15 Darko Antic  16 Pier Luigi Antignani  17 Manuel Monreal Bosch  18 Benjamin Brenner  19   20 Vladimir Chekhonin  21 Mary-Paula Colgan  22 Meletios-Athanasios Dimopoulos  23 Jim Douketis  24   25 Essam Abo Elnazar  26 Katalin Farkas  27 Bahare Fazeli  28 Gerry Fowkes  29 Yongquan Gu  30 Joseph Gligorov  1   31 Mark A Ligocki  13   14 Tishya Indran  32 Meganathan Kannan  33 Bulent Kantarcioglu  34 Abdoul Aziz Kasse  35 Kostantinos Konstantinidis  36 Fabio Leivano  14 Joseph Lewis  37 Alexander Makatsariya  6 P Massamba Mbaye  38 Isabelle Mahé  39 Irina Panovska-Stavridis  40 Dan-Mircea Olinic  41 Chryssa Papageorgiou  42 Zsolt Pecsvarady  43 Sergio Pillon  44 Eduardo Ramacciotti  45   46 Hikmat Abdel-Razeq  47 Michele Sabbah  1 Mouna Sassi  48 Gerit Schernthaner  49 Fakiha Siddiqui  50 Jin Shiomura  51 Anny Slama-Schwok  1 Jean Claude Wautrecht  52 Alfonso Tafur  53 Ali Taher  54 Peter Klein-Wegel  55 Zenguo Zhai  56   57 Tazi Mezalek Zoubida  58 Scientific Reviewer Committee
Collaborators, Affiliations

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

Grigoris T Gerotziafas et al. Thromb Haemost. 2021 Aug.

Abstract

Background: One year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis.

Management: Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program in many countries in late December 2020 with mRNA vaccines, adenovirus-based vaccines, and inactivated virus vaccines has generated hope for the end of the pandemic.

Current issues: The continuous appearance of new pathogenic viral strains and the ability of vaccines to prevent infection and transmission raise important concerns as we try to achieve community immunity against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and its variants. The need of a second and even third generation of vaccines has already been acknowledged by the WHO and governments.

Perspectives: There is a critical and urgent need for a balanced and integrated strategy for the management of the COVID-19 outbreaks organized on three axes: (1) Prevention of the SARS-CoV-2 infection, (2) Detection and early diagnosis of patients at risk of disease worsening, and (3) Anticipation of medical care (PDA).

Conclusion: The "PDA strategy" integrated into state policy for the support and expansion of health systems and introduction of digital organizations (i.e., telemedicine, e-Health, artificial intelligence, and machine-learning technology) is of major importance for the preservation of citizens' health and life world-wide.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Fig. 1
Fig. 1
Illustration of the PDA strategy: prevention of SARS-CoV-2 infection accelerated massive vaccination world-wide, epidemiological surveillance, masks, distancing, improvement of sanitary conditions, and setup of primary health care structures, which are capital elements for the mitigation and the control of the pandemic. PDA, prevention, detection, and anticipation.
Fig. 2
Fig. 2
Illustration of the PDA strategy: detection of the dynamics of the virus circulation of patients with COVID-19 and prompt identification of those at risk of disease worsening are mandatory to preserve the health of citizens and society's cohesion. PDA, prevention, detection, and anticipation.
Fig. 3
Fig. 3
Illustration of the PDA strategy: anticipation—medical treatment in patients with COVID-19 is essential for improved clinical outcome. Early identification of patients at risk of disease worsening and application of the recommended treatments at the level of the primary health care structures are related with improved clinical outcome and decreased mortality. The first 5 to 7 days after SARS-CoV-2 infection is a critical period for that requires identification of patients at risk of disease worsening and personalized therapeutic strategy. PDA, prevention, detection, and anticipation; VTE, venous thromboembolism.

References

    1. https://solidarites-sante.gouv.fr/IMG/pdf/avis_conseil_scientifique_6_ma...andhttps://www.lemonde.fr/podcasts/article/2021/06/30/le-variant-delta-peut-il-decl...
    1. Challen R, Brooks-Pollock E, Read J M, Dyson L, Tsaneva-Atanasova K, Danon L. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMJ. 2021;372(579):n579. - PMC - PubMed
    1. Garcia-Beltran W F, Lam E C, St Denis K. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021;184(09):2372–2.383E12. - PMC - PubMed
    1. Paul P, France A M, Aoki Y. Genomic Surveillance for SARS-CoV-2 variants circulating in the united states, December 2020-May 2021. MMWR Morb Mortal Wkly Rep. 2021;70(23):846–850. - PMC - PubMed
    1. Johanna N, Citrawijaya H, Wangge G. Mass screening vs lockdown vs combination of both to control COVID-19: a systematic review. J Public Health Res. 2020;9(04):2011. - PMC - PubMed

Substances